King Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
1.69 Bil |
| Income |
-478.77 Mil |
| Net Profit Margin |
-28.41% |
| Return on Equity |
-18.89% |
| Debt/Equity Ratio |
0.27 |
|
| Revenue/Share |
6.86 |
| Earnings/Share |
-1.97 |
| Book Value/Share |
9.41 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 429.1 | 432.0 | 516.0 |
| 2nd Qtr | 445.0 | 396.9 | 542.7 |
| 3rd Qtr | 463.3 | 388.4 | 544.9 |
| 4th Qtr | NA | 347.7 | 533.3 |
| Total | 1,337.4 | 1,565.1 | 2,136.9 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.04 | $0.35 | $0.48 |
| 2nd Qtr | $0.16 | $0.17 | $0.27 |
| 3rd Qtr | $0.17 | $0.34 | -$0.17 |
| 4th Qtr | NA | -$2.25 | $0.18 |
| Total | $0.29 | -$1.39 | $0.76 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 98% | 94% | --- |
| 2nd Qtr | NA | -51% | -44% |
| 3rd Qtr | 6% | 100% | NA |
| 4th Qtr | NA | NA | NA |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | -27% |
| 2nd Qtr | -6% | -37% |
| 3rd Qtr | -50% | NA |
| 4th Qtr | NA | NA |
advertisement
Recent News